Skip to content

Arthrocare System 12000

by Arthrocare Corp.

510(k) K071709

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK071709 Date7 Aug 2007ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GEI
Device Class
Class II
Regulation
21 CFR Part 878.4400
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Arthrocare System 12000 is an electrosurgical device that utilizes radiofrequency energy to treat tissue. It functions by passing energy through a conductive solution, such as normal saline or Ringer's lactate, which is applied in close proximity to or in contact with the target tissue.

This system operates by forming a thin layer of conductive solution between the active and return electrode elements to facilitate ablation. The device received FDA 510(k) clearance on August 7, 2007, under the reference number K071709.

Other devices from ArthroCare Corporation

See all devices from ArthroCare Corporation →

Questions

AI-generated answers, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • How does the Arthrocare System 12000 function?

    The system operates by utilizing radiofrequency energy passed through a conductive solution, such as normal saline or Ringer's lactate. This process creates a thin layer of conductive fluid between the active and return electrodes to facilitate the ablation of target tissue.

  • What is the regulatory status of this device?

    The Arthrocare System 12000 received FDA 510(k) clearance on August 7, 2007, under the reference number K071709. This indicates the device was determined to be substantially equivalent to legally marketed predicate devices.

  • What types of conductive solutions are compatible with this system?

    The device is designed to function with conductive solutions applied in close proximity to or in contact with the target tissue, specifically identifying normal saline or Ringer's lactate as appropriate mediums for energy transmission.